Live prices from 28 SA suppliers, from R349.00, compared side by side so you never overpay.
Copy the code — you'll paste it at checkout.
with our exclusive code
You're about to visit an external supplier
with our exclusive code
By clicking "Continue", you acknowledge that you understand and accept the above. Read our full disclosure.
Compare 38 prices for PT-141. Cheapest: R349.00. Average: R654.50.
| Compare | Visit | |||||||
|---|---|---|---|---|---|---|---|---|
JP Research
Best
PT-141 |
R349.00 | R34.90/mg | In Stock | Free |
Lab Tested
|
— | ||
|
PT-141 10mg |
R350.00 | R35.00/mg | In Stock | R170.00 |
—
|
— | ||
|
PT-141 10mg |
R363.00 | R36.30/mg | In Stock | R170.00 |
—
|
— | ||
|
PT-141 10mg |
R380.00 | R38.00/mg | In Stock | R150.00 |
Lab Tested
|
— | ||
|
PT-141 10mg |
R400.00 | R40.00/mg | In Stock | Free over R4,000 |
—
|
— | ||
|
PT-141 10mg |
R410.00 | R41.00/mg | In Stock | R250.00 |
Lab Tested
|
— | Unavailable | |
|
PT-141 10mg |
R450.00 | R45.00/mg | In Stock | R120.00 |
—
|
— | ||
|
PT-141 10mg |
R459.00 | R45.90/mg | In Stock | R250.00 |
—
|
— | ||
|
PT-141 10mg |
R460.00 | R46.00/mg | In Stock | R170.00 |
—
|
— | ||
|
PT-141 10mg |
R490.00 | R49.00/mg | In Stock | R170.00 |
—
|
— | ||
|
PT-141 10mg |
R500.00 | R50.00/mg | In Stock | Free over R2,000 |
—
|
— | ||
|
PT-141 10mg |
R500.00 | R50.00/mg | In Stock | R170.00 |
—
|
— | ||
|
PT-141 10mg |
R500.00 | R50.00/mg | In Stock | R250.00 |
—
|
— | Unavailable | |
|
PT-141 Nasal |
R520.00 | R52.00/mg | In Stock | R150.00 |
Lab Tested
|
— | ||
|
PT-141 |
R525.00 | R52.50/mg | In Stock | R99.00 |
Lab Tested
|
— | ||
|
PT-141 |
R540.00 | R54.00/mg | In Stock | R200.00 |
—
|
— | ||
|
PT-141 10mg |
R550.00 | R55.00/mg | In Stock | R95.00 |
Lab Tested
|
— | ||
|
PT-141 10mg |
R583.00 | R58.30/mg | Out of Stock | R185.00 |
Lab Tested
|
— | ||
|
PT-141 10mg |
R583.00 | R58.30/mg | In Stock | R170.00 |
—
|
— | ||
|
PT-141 10mg |
R605.00 | R60.50/mg | In Stock | R250.00 |
—
|
— | ||
|
PT-141 10mg |
R625.00 | R62.50/mg | In Stock | R100.00 |
—
|
— | ||
|
PT-141 Pen |
R628.00 | R62.80/mg | In Stock | R150.00 |
Lab Tested
|
— | ||
|
PT-141 10mg |
R650.00 | R65.00/mg | In Stock | R140.00 |
—
|
— | ||
|
PT-141 10mg |
R650.00 | R65.00/mg | In Stock | R250.00 |
—
|
— | ||
|
PT-141 10mg |
R665.85 | R66.59/mg | In Stock | R250.00 |
Lab Tested
|
— |
Showing 25 of 37 listings
More ways to compare PT-141
Different views of the same live SA pricing, tuned for how you like to shop.
Compare another peptide
All purchases are made directly from third-party suppliers; your relationship is solely with them. We accept no liability for the quality, purity, or legality of any products listed.
We may earn a commission when you click through to a supplier and make a purchase. This does not affect pricing information displayed.
By using this site you accept responsibility for ensuring purchases comply with applicable laws in your jurisdiction. Read our full disclosure.
Melanocortin Receptor Agonist | Sexual Dysfunction Treatment
FDA-approved melanocortin receptor agonist for treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. Works centrally in the nervous system to trigger sexual arousal pathways independent of vascular mechanisms, unlike traditional ED medications.
Selectively activates melanocortin receptors (MC3R/MC4R) in the central nervous system, triggering sexual arousal pathways independent of peripheral vascular mechanisms. Works within 45 minutes with effects lasting 6-12 hours.
FDA-approved for treatment of HSDD in premenopausal women.
Effective in men including PDE5 inhibitor-resistant cases via CNS pathways.
Enhances sexual arousal and desire in women.
Reduces distress related to low sexual desire.
Enhanced satisfaction reported in clinical trials.
Subcutaneous injection is the FDA-approved route. Administered 45-60 minutes before anticipated sexual activity.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Female HSDD (FDA-approved) | 1.75mg | As needed, max 1 dose/24hr | SubQ |
| Male Erectile Dysfunction | 1-2mg | As needed, 45-60min before activity | SubQ |
| Female Arousal Disorder | 0.75-1.25mg | As needed, max 1 dose/24hr | SubQ |
| Low Starting Dose | 0.5mg | Test dose for tolerance assessment | SubQ |
Intranasal spray with faster onset (30-45 minutes). Limited clinical data compared to injectable.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Male ED - Standard | 1.5-2mg | As needed, 30-45min before | Nasal |
| Female Sexual Dysfunction | 1-1.5mg | As needed, max 1 dose/24hr | Nasal |
PT-141 works centrally; PDE5 inhibitors work peripherally - monitor for additive BP effects.
Both are melanocortin agonists; combining risks excessive activation and side effects.
PT-141 can transiently lower blood pressure - monitor closely.
Both lower BP and cause flushing - limit intake to avoid excessive hypotension.
Risk of severe hypotension - contraindicated with heart condition medications.
Different mechanisms; no known interactions.
May work synergistically for sexual dysfunction through different pathways.
Different pathways (melanocortin vs GnRH) - no receptor overlap but monitor BP effects.
Mild nausea or facial flushing possible
Onset of effects - increased arousal and desire
Peak effects - enhanced sexual response
Gradual diminishment of effects
Journal of Sexual Medicine
Real-world data of 10,000+ prescriptions shows consistent safety profile.
International Journal of Impotence Research
Demonstrates effectiveness in patients who failed traditional ED medications.
Phase 3 trials with 1.75mg subcutaneous in premenopausal women showed 24.5% improvement vs 17.2% placebo, achieving statistical significance.
1-20mg intranasal showed dose-dependent erectile response, effective including in PDE5 inhibitor-resistant cases via CNS pathways.
In vitro and animal studies confirmed selective MC3R/MC4R binding activating sexual arousal without peripheral vasodilation.
Plain-English guides and study summaries from published literature.
Be the first to know when prices drop on your favourite peptides
No spam. Unsubscribe anytime. We respect your privacy.
